Cellular mechanisms in the development and progression of diabetic nephropathy: Activation of the DAG-PKC-ERK pathway

This publication has 17 references indexed in Scilit:

• Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats.
  Diabetes, 2000
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Protein kinase C activation and the development of diabetic complications.
  Diabetes, 1998
• Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
  Journal of Clinical Investigation, 1997
• Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator
  Diabetes, 1995
• Translocation of protein kinase C ? and ? in rat glomerular mesangial cells cultured under high glucose conditions
  Diabetologia, 1994
• The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1993
• Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells
  Metabolism, 1990
• Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose.
  Journal of Clinical Investigation, 1989
• Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
  New England Journal of Medicine, 1988